The event is expected to be attended by 40 senior-level pharmaceutical leaders to discuss the drivers for change in pharma and how they can move and change quickly to sustain growth in these turbulent times.
The organisers have said that the event has been born out of the huge pressures pharma is facing right now: pricing pressures; increasing payor power and decreasing prescriber power; and the mounting stress on margins.
Senior-level leaders from across Europe will meet to discuss these issues and come to solutions and analyse strategies that will help resolve some of these challenges.
Key on the agenda of The Selling Pharmaceuticals in 2015 conference will be how other industries such as the airlines or IT have dealt with similar changes. The event will bring together Jeff Foland, senior VP worldwide sales, United Airlines; Joshua Rossman, formerly head of value sales team, Cisco Systems, and director of enterprise and partnership, Microsoft; and Charles Bellaiche, regional SAM director, Hewlett-Packard, to find out what strategies they have used to combat commoditisation and a low value commercial interaction.
Joining them will be key figures from big to medium size pharma in Europe to discuss and debate how this can be applied in pharma, and also find out what has and hasn’t worked in the past. Amongst others, Belen Garijo, senior vice president Pharmaceutical Operations Europe and Canada, sanofiaventis; Otto Schwarz, senior vice president commercial, Actelion; Marc de Garidel, head of operations southern Europe, Amgen and Alexandre Moreau, global franchise director, sanofiaventis, will speak about what they have done and are planning to do to move their companies from selling products at a price to selling real value and what the implementation challenges are in doing this.